Meeting
2021 Gastrointestinal Cancers Symposium
In search of novel synthetic lethality anti-cancer drug targets in intrahepatic cholangiocarcinoma: MTAP genomic loss.
Authors
Jeffrey S. Ross
Foundation Medicine, Cambridge, MA
Jeffrey S. Ross , Alexa Betzig Schrock , Russell Madison , Natalie Danziger , Dean Pavlick , Ethan Sokol , Amanda Hemmerich , Richard Huang , Shakti H. Ramkissoon , Mason A. Israel , Ole Gjoerup , Jeffrey Michael Venstrom , Kimberly McGregor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Hepatobiliary Cancer
Track
Hepatobiliary Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 337)
DOI
10.1200/JCO.2021.39.3_suppl.337
Abstract #
337
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of PD-L1 expression on conventional urothelial bladder carcinoma (UBC) genomic alteration (GA) profile.
First Author: Petros Grivas
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Peri-hilar cholangiocarcinoma (phCCA): A comparative comprehensive genomic profiling study.
First Author: Parth J Sampat
First Author: Tin-Yun Tang
Poster
2019 ASCO Annual Meeting
Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).
First Author: Milind M. Javle